Biomay is Expanding its Manufacturing Capacities

Biomay is building a new manufacturing facility entirely dedicated to its CDMO business. The new site is located in award-winning "Seestadt Aspern" - a newly formed urban district in the north-east of Vienna.

Facts of Biomay´s Seestadt Facility

  • State-of -the-art and fully integrated multipurpose biomanufacturing facility
  • Construction work started in September 2020
  • GMP operations to begin in Q1/2022.

Scope of Services in the New Facility

  • Plasmid DNA, messenger RNA, recombinant proteins (microbial derived)
  • Quality grades: cGMP, and High Quality (HQ)
  • One-Stop-Shop:

    • Vector construction and cell banking
    • Process- and analytical development
    • Manufacturing drug substance and GMP starting material
    • Manufacturing drug product / aseptic filling
    • Quality control predominantly in-house

 

Manufacturing Capacities

  • Bioreactor scales (gross): 750 L , 150 L, 50 L, 5 L (multiple)
  • Clean room areas: class A (ISO 5), class B (ISO 5), class C (ISO 7), class D (ISO 8)
  • Dedicated area for personalized (patient specific) batches

 

Location Seestadt Vienna:

Biomay´s new site is located in the attractive and representative surrounding of an exciting, young, and urban region of Vienna. Seestadt Aspern can be reached within 30 minutes from the airport, as well as from Vienna city center (underground U2).

Read more about Seestadt ...